Pfizer stock rose moderately early Tuesday as better-than-expected Covid product sales helped drive a fourth-quarter beat.
The post Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations appeared first on Investor’s Business Daily.
Pfizer stock rose moderately early Tuesday as better-than-expected Covid product sales helped drive a fourth-quarter beat.
The post Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations appeared first on Investor’s Business Daily.